With a prevalence of about 1% of the total population, schizophrenia is a significant mental health problem worldwide and stressful for patients and their families (
1,
2). In Iran, prevalence studies have revealed that 78% of people in the countryside experience schizophrenia (
3). Although antipsychotic drugs are the primary treatment for schizophrenic patients, despite their effectiveness, about two-thirds of patients may experience positive and negative symptoms during their lifetime (
4). Based on the presence or absence of positive and negative symptoms, schizophrenia can be divided into two types, one and two. Positive symptoms include hallucinations, delusions, abnormal behavior, and thought disorders. The brain structure in these patients is normal, and they respond well to treatment. Negative symptoms include anhedonia, apathy, flat affect, and lack of attention. In addition, there are abnormalities in the brain structure of these patients. Also, these patients do not respond well to treatment (
5). One of the biggest challenges in the treatment of schizophrenic patients is the treatment of negative symptoms. Sometimes even a year after the last episode of the disease, negative symptoms are seen in about 50% of patients (
6).
Compared to other psychiatric disorders, most psychiatric beds are reserved for patients with schizophrenia (
7). Living with a person with a mental health condition has difficulties, some of which are family exhaustion, worry about the recurrence of syndrome symptoms, misgiving about the cause of the disorder, and the stigma of mental illness (
8). However, established family environments can predict improving symptoms and social functioning in psychiatric patients (
9). Accordingly, family caregivers can be valuable for patients facing major psychiatric disorders. Therefore, by increasing their knowledge about the family member’s disorder, they can help their sick member through therapeutic support (
10). This has caused more attention to the patient’s living environment in the last decade. According to experts, as the patient’s life context plays a fundamental role in improving or worsening the disease and its prognosis, this issue has led mainly to the expansion of psychological interventions (focusing on the patient’s primary caregivers) (
11). Such treatment programs focused on caregivers can help the family better understand the disorder’s nature, therapeutic interventions, and prognosis (
12).
According to the meta-analyses, drug therapy can only have limited effects on the negative symptoms of schizophrenia (
13). In their study, Leucht et al. showed that only four groups of second-generation antipsychotics were more effective than first-generation antipsychotics in negative disease symptoms (with an effect size between 0.13 and 0.32). Also, in the analogy between second-generation antipsychotics and placebo, the mean difference (0.39) favored second-generation drugs (
14). There is good evidence that pharmacotherapy combined with family-focused programs is a more effective treatment for schizophrenia than medication alone (
15).
However, Makinen et al. indicated that the impact of programs focused on the primary caregivers of patients or psychological education to them did not have satisfactory effects on the negative symptoms of patients (
16). However, many meta-analyses have provided evidence of the effectiveness of cognitive behavioral therapy (CBT) on the symptoms of schizophrenia, emphasizing CBT for routine care (RC) in the treatment of schizophrenia (
17). According to Hassan et al.’s research, the psychoeducational program showed a significant improvement in the severity of the disease symptoms immediately and three months after the intervention (
18). Also, Kheirabadi et al. (
19) evaluated the efficacy of a need-assessment–based educational program compared with a current program (textbook based) in treating schizophrenia. They concluded that the Positive and Negative Syndrome Scale (PANSS) total score in both experimental and control groups was significantly decreased, but this decrease was considerably more in the intervention group than in the control group. However, the separate scores of positive and negative symptoms decreased only in the intervention group, and the decrease in these scores was not significant in the control group. The response rate was higher in the intervention group, and the relapse rate was lower in this group. In logistic regression analysis, need–assessment–based psycho-education was associated with more treatment response. In Sharif et al.’s study (
20), in the experimental group, the intensity of the disorder’s symptoms and the pressure on the patient’s caregivers significantly decreased immediately and two months after the intervention.
In the present article, we report the effects of familial psychoeducational intervention and medication strategies on patients’ positive and negative symptoms. In a randomized study, psycho-social rehabilitation training and single drug control by Wang et al. (
21), the intervention group showed significantly lower scores on the scale of positive and negative symptoms of schizophrenia than the control group after treatment.